63K-91331-63125 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Dose 1 — Janssen/Johnson & Johnson
2021-04-06
Registered in v-safe
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-26
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-05-03
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-07-05
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-10-04
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-10-31
Dose 2 — Pfizer-BioNTech
2021-11-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Abdominal pain

Adult check-in
2021-11-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-11-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-11-07
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-11-14
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-21
Survey response — day 21, dose 2
MedDRA: Nasal congestion, Nasopharyngitis, Paranasal sinus discomfort, Productive cough — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Head cold stuffy nose sinus pressure and productive cough

MedDRA releases: 2024-11 · check-in free text available
2021-11-28
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-12-07
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-12-12
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-05-01
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-10-31
Survey response — 12 months, dose 2
MedDRA: Eczema, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Eczema and hives

MedDRA releases: 2024-11 · check-in free text available
2022-10-31
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-01
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-05	Janssen/Johnson & Johnson
2	2021-10-31	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-31	Successful 2022-11-01	Participant prefers to complete VAERS report online

Free text

Release 10 — day 21, dose 2

2021-11-21

Symptoms: Head cold stuffy nose sinus pressure and productive cough

Release 12 — 12 months, dose 2

2022-10-31

Symptoms: Eczema and hives

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Eczema	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Paranasal sinus discomfort	·	·	✓
SD	Productive cough	·	·	✓
SD	Urticaria	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release